Clinical Trial

Genetic Analysis of Keloids

Recruiting
View on ClinicalTrials.gov →
Summary
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2012-06-13; most recent amendment 2026-04-14.
Trial Details
NCT Number NCT01619553
Lead Sponsor UConn Health
Conditions Keloid
Enrollment 7,000 participants
Start Date 2009-04
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-15